BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32056180)

  • 1. Liquid Biopsy for Investigation of Cancer DNA in Esophageal Squamous Cell Carcinoma.
    Smith RA; Lam AK
    Methods Mol Biol; 2020; 2129():203-215. PubMed ID: 32056180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid Biopsy: Detection of Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma.
    Lam AK; Hamid FB; Gopalan V
    Methods Mol Biol; 2020; 2129():193-202. PubMed ID: 32056179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid Biopsy for Investigation of Cancer DNA in Esophageal Adenocarcinoma: Cell-Free Plasma DNA and Exosome-Associated DNA.
    Smith RA; Lam AK
    Methods Mol Biol; 2018; 1756():187-194. PubMed ID: 29600371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy of oesophageal squamous cell carcinoma: implications in diagnosis, prognosis, and treatment monitoring.
    Hao MJ; Cheng ZY; Gao Y; Xin L; Yu CT; Wang TL; Li ZS; Wang LW
    Scand J Gastroenterol; 2024 Jun; 59(6):698-709. PubMed ID: 38466190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detention and Identification of Cancer Stem Cells in Esophageal Squamous Cell Carcinoma.
    Islam F; Gopalan V; Lam AK
    Methods Mol Biol; 2020; 2129():177-191. PubMed ID: 32056178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome Sequencing in Esophageal Squamous Cell Carcinoma.
    Pillai S; Maksemous N; Lam AK
    Methods Mol Biol; 2020; 2129():217-240. PubMed ID: 32056181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA profiling and its potential for esophageal squamous cell cancer diagnosis and prognosis.
    Fan L; Cao Q; Liu J; Zhang J; Li B
    Mol Cancer; 2019 Jan; 18(1):16. PubMed ID: 30674324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-region sequencing reveals genetic correlation between esophageal squamous cell carcinoma and matched cell-free DNA.
    Yuan Z; Wang X; Geng X; Li Y; Tan F; Xue Q; Gao S; He J
    Cancer Genet; 2021 Nov; 258-259():93-100. PubMed ID: 34688997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Spectrometry for Biomarkers Discovery in Esophageal Squamous Cell Carcinoma.
    Islam F; Gopalan V; Lam AK
    Methods Mol Biol; 2020; 2129():259-268. PubMed ID: 32056183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-lncRNA signature in plasma exosomes serves as diagnostic biomarker for esophageal squamous cell carcinoma.
    Jiao Z; Yu A; Rong W; He X; Zen K; Shi M; Wang T
    Aging (Albany NY); 2020 Jun; 12(14):15002-15010. PubMed ID: 32597791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of MicroRNAs in Esophageal Squamous Cell Carcinoma Pathogenesis.
    Islam F; Gopalan V; Lam AK
    Methods Mol Biol; 2020; 2129():241-257. PubMed ID: 32056182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updates of liquid biopsy in oral cancer and multiomics analysis.
    Zhang X; Li B
    Oral Dis; 2023 Jan; 29(1):51-61. PubMed ID: 34716963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.
    Junqueira-Neto S; Batista IA; Costa JL; Melo SA
    Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ-SLC7A5, a potential prognostic circulating biomarker for detection of ESCC.
    Wang Q; Liu H; Liu Z; Yang L; Zhou J; Cao X; Sun H
    Cancer Genet; 2020 Jan; 240():33-39. PubMed ID: 31726270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid Biopsy: General Concepts.
    Poulet G; Massias J; Taly V
    Acta Cytol; 2019; 63(6):449-455. PubMed ID: 31091522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Assays of Biological Aggressiveness of Esophageal Squamous Cell Carcinoma.
    Islam F; Gopalan V; Lam AK
    Methods Mol Biol; 2020; 2129():161-175. PubMed ID: 32056177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma.
    Yang L; Salai A; Sun X; Liu Q; Liu T; Zhang Q; Tuerxun A; Tan Y; Zheng S; Lu X
    J Proteomics; 2022 Aug; 265():104662. PubMed ID: 35728771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
    Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
    Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide and size-based cell-free DNA indices as predictive biomarkers for locally advanced esophageal squamous cell carcinoma treated with preoperative or definitive chemoradiotherapy.
    Kim EJ; Im HS; Lee J; Cho EH; Kim YH; Kim HR; Kim JH; Park SR
    Curr Probl Cancer; 2021 Jun; 45(3):100685. PubMed ID: 33342577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoblotting in Detection of Tumor-Associated Antigens in Esophageal Squamous Cell Carcinoma.
    Islam F; Gopalan V; Lam AK
    Methods Mol Biol; 2020; 2129():269-277. PubMed ID: 32056184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.